X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22) 22
humans (17) 17
aged (16) 16
female (15) 15
hematology (15) 15
male (15) 15
aged, 80 and over (11) 11
middle aged (9) 9
rituximab (9) 9
oncology (8) 8
chemotherapy (7) 7
elderly-patients (7) 7
lymphomas (7) 7
r-chop (7) 7
treatment outcome (7) 7
aged patients (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
cyclophosphamide (6) 6
prognosis (6) 6
risk factors (6) 6
adult (5) 5
analysis (5) 5
antibodies, monoclonal, murine-derived - adverse effects (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
cancer (5) 5
elderly (5) 5
mortality (5) 5
non-hodgkin-lymphoma (5) 5
phase-ii (5) 5
validation (5) 5
antibodies, monoclonal, murine-derived - administration & dosage (4) 4
cyclophosphamide - adverse effects (4) 4
doxorubicin - adverse effects (4) 4
high-dose chemotherapy (4) 4
italy (4) 4
logistic models (4) 4
lymphoma, large b-cell, diffuse - diagnosis (4) 4
lymphoma, large b-cell, diffuse - drug therapy (4) 4
medicine, general & internal (4) 4
non-hodgkins-lymphoma (4) 4
plus rituximab (4) 4
polypharmacy (4) 4
prednisone - adverse effects (4) 4
risk (4) 4
rituximab-chop (4) 4
therapy (4) 4
vincristine - adverse effects (4) 4
age factors (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
b-cell lymphoma (3) 3
chronic diseases (3) 3
combination (3) 3
cyclophosphamide - administration & dosage (3) 3
dexamethasone (3) 3
diffuse large b-cell lymphoma (3) 3
doxorubicin - administration & dosage (3) 3
follicular lymphoma (3) 3
geriatrics & gerontology (3) 3
health aspects (3) 3
hemic and lymphatic diseases (3) 3
infectious diseases (3) 3
italy - epidemiology (3) 3
lenalidomide (3) 3
lymphoma (3) 3
lymphoma, large b-cell, diffuse - mortality (3) 3
lymphoma, large b-cell, diffuse - therapy (3) 3
management (3) 3
medical research (3) 3
medicine & public health (3) 3
medicine, experimental (3) 3
multimorbidity (3) 3
pharmacology & pharmacy (3) 3
prednisone - administration & dosage (3) 3
recurrence (3) 3
retrospective studies (3) 3
risk assessment (3) 3
stem cells (3) 3
survival (3) 3
transplantation (3) 3
vincristine - administration & dosage (3) 3
1st-line treatment (2) 2
anticoagulants (2) 2
antigens (2) 2
aspirin (2) 2
association (2) 2
care and treatment (2) 2
cns lymphoma (2) 2
comorbidities (2) 2
comorbidity (2) 2
consolidation chemotherapy (2) 2
corticosteroids (2) 2
cytarabine (2) 2
detude des lymphomes (2) 2
dexamethasone - administration & dosage (2) 2
diffuse large b cell lymphoma (2) 2
diseases of the blood and blood-forming organs (2) 2
doxorubicin (2) 2
drug therapy (2) 2
etoposide (2) 2
follow-up studies (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 730 - 737
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2013, Volume 110, Issue 9, pp. 3304 - 3309
Mapping of epitopes recognized by functional monoclonal antibodies (mAbs) is essential for understanding the nature of immune responses and designing improved... 
Proteins | Antigens | Pathogens | Carrier proteins | Vaccination | Epitope mapping | Antibodies | Neisseria meningitidis | Libraries | Epitopes | Surface plasmon resonance | Structural mass spectrometry | Structure | Antigen-antibody complex | Meningococcus | SURVIVAL | antigen-antibody complex | surface plasmon resonance | BACTERICIDAL ANTIBODY | MULTIDISCIPLINARY SCIENCES | NEISSERIA-MENINGITIDIS | SEROGROUP-B | MONOCLONAL-ANTIBODY | structural mass spectrometry | meningococcus | structure | REGION | Meningococcal Infections - immunology | Surface Plasmon Resonance | Epitope Mapping | Antigens, Bacterial - immunology | Bacterial Proteins - chemistry | Crystallography, X-Ray | Virulence Factors - immunology | Meningococcal Infections - microbiology | Epitopes - immunology | Neisseria meningitidis - immunology | Deuterium Exchange Measurement | Antibody Specificity - immunology | Mass Spectrometry | Bacterial Proteins - immunology | Antibodies, Monoclonal - immunology | Neisseria meningitidis - pathogenicity | Antigens, Bacterial - chemistry | Peptides - chemistry | Peptides - immunology | Models, Molecular | Meningococcal Infections - prevention & control | Virulence Factors - chemistry | Protein Binding - immunology | Cell Surface Display Techniques | Epitopes - chemistry | Meningococcal Vaccines - immunology | Physiological aspects | Virulence (Microbiology) | Research | Binding proteins | Drug therapy | Health aspects | Meningococcal infections | Biological Sciences
Journal Article
The Lancet Oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
The prognosis of young patients with diffuse large B-cell lymphoma at high risk (age-adjusted International Prognostic Index [aa-IPI] score 2 or 3) treated... 
CLINICAL-PRACTICE GUIDELINES | SURVIVAL | SUPPORT | IMPACT | CONSOLIDATION | RESPONSE CRITERIA | ONCOLOGY | R-CHOP | NON-HODGKIN-LYMPHOMA | ELDERLY-PATIENTS | MEGACHOEP | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Consolidation Chemotherapy | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Intention to Treat Analysis | Vincristine - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Carmustine - administration & dosage | Stem Cell Transplantation - adverse effects | Stem cells
Journal Article
Haematologica, ISSN 0390-6078, 11/2013, Volume 98, Issue 11, pp. 1732 - 1738
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2019, Volume 94, Issue 3, pp. 291 - 298
Journal Article
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 2017, Volume 9, Issue 1, pp. e2017009 - e2017009
Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma, which typically affects mature adults and elderly, whose median age at diagnosis is... 
Comorbidities | Follicular lymphoma | Elderly | 1ST-LINE TREATMENT | INFECTIOUS DISEASES | PLUS RITUXIMAB | MAINTENANCE THERAPY | Follicular Lymphoma | MANTLE-CELL LYMPHOMAS | TIUXETAN CONSOLIDATION | INDOLENT LYMPHOMA | NON-HODGKIN-LYMPHOMA | TERM-FOLLOW-UP | RETROSPECTIVE ANALYSIS | HEMATOLOGY | DETUDE DES LYMPHOMES | Follicular Lymphoma, Elderly, Comorbidities
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4139 - 4139
Abstract Introduction. The peripheral blood absolute lymphocyte (ALC)/monocyte (AMC) ratio (ALC/AMC), as a surrogate of host immunity (i.e. ALC) and tumor... 
Journal Article
Cancers, ISSN 2072-6694, 11/2019, Volume 11, Issue 12, p. 1831
Mantle cell lymphoma (MCL) is an aggressive lymphoma subtype with poor prognosis in which 18F-FDG-PET/CT role in treatment response evaluation and prediction... 
mantle cell lymphoma | 18f-fdg pet/ct | prognosis | deauville criteria
Journal Article
Annals of Hematology, ISSN 0939-5555, 9/2018, Volume 97, Issue 9, pp. 1619 - 1626
Chemo-refractory NHL has a very poor outcome; the addiction of RIT to salvage regiment pre ASCT had recently demonstrated promising results.We performed a... 
Oncology | Medicine & Public Health | Hematology | Aggressive refractory NHL | Zevalin | Autologous stem cell transplantation | CYCLOPHOSPHAMIDE | RADIOIMMUNOTHERAPY | PHASE-II | CYTARABINE | COMBINATION | TRIAL | YTTRIUM-90-IBRITUMOMAB TIUXETAN | ETOPOSIDE | RITUXIMAB | HIGH-DOSE CHEMOTHERAPY | HEMATOLOGY | Recurrence | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Podophyllotoxin - therapeutic use | Male | Transplantation, Autologous | Melphalan - therapeutic use | Yttrium Radioisotopes - administration & dosage | Lymphoma, Non-Hodgkin - pathology | Young Adult | Carmustine - therapeutic use | Adult | Female | Retrospective Studies | Transplantation Conditioning - methods | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Neoplasm Invasiveness | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Combined Modality Therapy | Lymphoma, Non-Hodgkin - epidemiology | Lymphoma, B-Cell - epidemiology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Non-Hodgkin - therapy | Adolescent | Lymphoma, B-Cell - pathology | Italy - epidemiology | Aged | Salvage Therapy - methods | Drug Resistance, Neoplasm - drug effects | Rare earth metals | Antimitotic agents | Chemotherapy | Stem cells | Transplantation | Lymphomas | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Expert Review of Hematology, ISSN 1747-4086, 04/2017, Volume 10, Issue 4, pp. 289 - 297
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common histotype in non Hodgkin lymphoma, with a peak incidence in the sixth decade. The... 
fit | Diffuse large B cell lymphoma | comprehensive geriatric assessment | frail | rituximab-CHOP | unfit | CYCLOPHOSPHAMIDE | R-CHOP | TYROSINE KINASE | PLUS RITUXIMAB | CHEMOTHERAPY | PHASE-II TRIAL | LIPOSOMAL DOXORUBICIN | PATIENTS OLDER | LENALIDOMIDE | HEMATOLOGY
Journal Article
Clinical Research in Cardiology, ISSN 1861-0684, 11/2016, Volume 105, Issue 11, pp. 912 - 920
Journal Article
Expert Review of Hematology, ISSN 1747-4086, 08/2017, Volume 10, Issue 8, pp. 697 - 705
Introduction: Diffuse Large B-cell Lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma (NHL), with an incidence in Europe of 3.8/100.000/year.... 
ibrutinib | Diffuse large B cell lymphoma | rituximab-CHOP | lenalidomide | venetoclax | novel drugs | tazemetostat | MOLECULAR SUBTYPES | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | R-CHOP | DOXORUBICIN | PHASE-II | LENALIDOMIDE MONOTHERAPY | VINCRISTINE | GENE-EXPRESSION | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | ELDERLY-PATIENTS
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2962 - 2962
Abstract Introduction: Lenalidomide (Len) in association with standard Rituximab-CHOP (R2CHOP21) has been shown to be safe and effective in newly diagnosed... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 574 - 574
Abstract Introduction. Vitreoretinal lymphoma (VRL) is a rare ocular malignancy. Diagnosis and optimal treatment remain a challenge for clinicians. We present... 
Journal Article